Targeting Angiopoietin-2: A New Approach in Retinal Diseases

Can anything improve anti-vascular epithelial growth factor (anti-VEGF) control of exudation in retinal disease? Learn how targeting the angiopoietin pathway may help. Credit available for this activity expires: 6/23/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975535?src=mkm_podcast_addon_975535